Nuwellis Inc. Common Stock (NUWE)
Stock · NASDAQ · Health Care
$0.5521as of 10/16/2026
Price chart
Active signals
NUWE Signal Track Record
How signals performed across all stocks →What NUWE's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 26 | -16.8% | 19% | July 23, 2026 |
| Bollinger Band Breakout | 15 | -33.3% | 13% | July 30, 2026 |
| Volume Spike | 5 | -46.6% | 0% | September 17, 2026 |
| Any 20-session window (baseline) | -19.8% | 22% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NUWE
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutio…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 38
- Website
- www.nuwellis.com/
Fundamentals
- 1-day range
- $0.53$0.5766
- Market cap
- $5.26M
- P/E (trailing)
- 0.03
- P/E (forward)
- -0.21
- EPS (trailing)
- $-136.17
- Dividend yield
- —
- Beta
- 0.10
- Avg. volume
- 4.33M
- Dividend pay date
- October 19, 2020
How Nuwellis Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 11, 2025 · via SEC EDGAR / Finnhub
Nuwellis Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NUWENuwellis Inc. Common Stock$0.55▲ 0.00%Market cap $5.26MP/E 0.03$0.4444$172.9
- ITOCiTonic Holdings Ltd Class A Ordinary Shares$3.84▼ 4.24%Market cap $4.94MP/E —$3.51$18.4
- NDRAENDRA Life Sciences Inc. Common Stock$4.74▼ 7.06%Market cap $5.68MP/E —$2.96$8
- NXLNexalin Technology Inc. Common Stock$2.35▼ 4.08%Market cap $7.45MP/E —$2.38$50.7
- VBIOValion Bio Inc. Common Stock$1.17▼ 4.88%Market cap $1.14MP/E —$1.11$32.5
- IRIXIRIDEX Corporation Common Stock$0.81▼ 1.22%Market cap $14.61MP/E —$0.607$1.65
- QTIQT Imaging Holdings Inc. Common Stock$2.4▲ 0.84%Market cap $37.38MP/E —$2.38$19.05
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NUWE Nuwellis Inc. Common Stock | $5.26M | 0.03 | $0.55 | ▲ 0.00% | $0.4444$172.9 |
| ITOC iTonic Holdings Ltd Class A Ordinary Shares | $4.94M | — | $3.84 | ▼ 4.24% | $3.51$18.4 |
| NDRA ENDRA Life Sciences Inc. Common Stock | $5.68M | — | $4.74 | ▼ 7.06% | $2.96$8 |
| NXL Nexalin Technology Inc. Common Stock | $7.45M | — | $2.35 | ▼ 4.08% | $2.38$50.7 |
| VBIO Valion Bio Inc. Common Stock | $1.14M | — | $1.17 | ▼ 4.88% | $1.11$32.5 |
| IRIX IRIDEX Corporation Common Stock | $14.61M | — | $0.81 | ▼ 1.22% | $0.607$1.65 |
| QTI QT Imaging Holdings Inc. Common Stock | $37.38M | — | $2.4 | ▲ 0.84% | $2.38$19.05 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT SystemYahoo · 10/8/2026
- Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical ConferencesYahoo · 10/1/2026
- Nuwellis To Participate In Four Medical Conference This Month To Present Data, Discuss Role Of Its Aquadex SmartFlow SystemBenzinga · 10/1/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 9/18/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 9/18/2026
- Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue OpportunityYahoo · 9/17/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 9/17/2026
- Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue OpportunityYahoo · 9/17/2026
Insider Activity
Insider Actions →- Feldshon Archelle Georgiou · April 28, 2026 · Grant6.7K
- McDonald David · April 28, 2026 · Grant6.7K
- Emerson Martin J · April 28, 2026 · Grant6.7K
- WALLER GREGORY D · April 28, 2026 · Grant6.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
Nuwellis to Present Data at Four October Medical Conferences
Nuwellis Inc. is scheduled to participate in four major medical conferences this month. The company will present data and discuss the role of its Aquadex SmartFlow System in fluid management for pediatric, critical care, and heart failure settings. This activity highlights the firm's focus on advancing its technology within specific clinical areas.
Nuwellis to Present Data at Four October Medical Conferences. Nuwellis Inc. is scheduled to participate in four major medical conferences this month. The company will present data and discuss the role of its Aquadex SmartFlow System in fluid management for pediatric, critical care, and heart failure settings. This activity highlights the firm's focus on advancing its technology within specific clinical areas.